| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |